Central Automotive Products (8117) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 May, 2026Executive summary
Net sales rose 5.7% year-over-year to ¥41,558 million for the fiscal year ended March 31, 2025.
Operating profit increased 8.6% year-over-year to ¥11,040 million.
Profit attributable to owners of parent grew 9.6% year-over-year to ¥8,681 million.
Comprehensive income declined 15.3% year-over-year to ¥8,388 million.
Financial highlights
Gross profit improved to ¥18,428 million from ¥17,004 million year-over-year.
Operating margin was 26.6%, up from 25.8% the previous year.
Net assets increased to ¥55,701 million, with a capital adequacy ratio of 87.7%.
Cash and cash equivalents at year-end were ¥20,560 million, up from ¥17,343 million.
Dividend payout ratio rose to 33.7% with total dividends of ¥2,942 million.
Outlook and guidance
Forecast for FY2026: Net sales of ¥44,800 million (+7.8% YoY), operating profit of ¥11,800 million (+6.9%), and profit attributable to owners of parent of ¥9,000 million (+3.7%).
Basic earnings per share forecasted at ¥162.95 for FY2026.
Dividend forecast for FY2026 is ¥56.00 per share (post-stock split basis).
Latest events from Central Automotive Products
- Q1 FY2025 delivered stable profits and improved equity despite weak new car sales.8117
Q1 202526 May 2026 - Modest profit growth and higher dividends, with improved equity ratio and stable outlook.8117
Q2 202526 May 2026 - Profits rose on higher revenue and segment gains, with guidance maintained for the full year.8117
Q3 202526 May 2026 - Strong quarterly growth in sales and profits, with positive full-year guidance and stock split.8117
Q1 202626 May 2026 - Net sales and profits grew year-over-year, with strong guidance and a recent stock split.8117
Q2 202626 May 2026 - Net sales rose 12.8% and profit attributable to owners of parent increased 11.7% year-over-year.8117
Q3 202626 May 2026 - Sales and profits rose, cash flow strengthened, and FY2027 guidance remains positive.8117
Q4 202626 May 2026